Company

REME-D

REME-D develops diagnostic tools, including PCR kits and nucleic acid testing technologies.

About

REME-D develops nucleic acid extraction and amplification technologies for human and animal health, targeting healthcare providers, research institutions, and laboratories. Founded in 2023 by Dr. Salma Tammam, the company is based in Cairo, Egypt. It raised USD 1.45 million in pre-series A funding in July 2026, led by Anara Impact Capital, with participation from Africa Health Ventures and Global Innovation Fund.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in